ATW SPAC Management’s SBC Medical Group Warrants SBCWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$39.2K Hold
180,629
0.05% 87
2025
Q2
$34.9K Hold
180,629
0.05% 68
2025
Q1
$33.6K Hold
180,629
0.06% 58
2024
Q4
$43.4K Sell
180,629
-277,890
-61% -$67.1K 0.06% 52
2024
Q3
$68.8K Buy
+458,519
New +$47.4K 0.07% 52
2023
Q4
Sell
-458,519
Closed -$18.4K 205
2023
Q3
$27.5K Hold
458,519
0.04% 97
2023
Q2
$27.3K Hold
458,519
0.02% 117
2023
Q1
$21.7K Sell
458,519
-36,481
-7% -$2.36K 0.01% 117
2022
Q4
$27.3K Hold
495,000
0.01% 127
2022
Q3
$50K Buy
+495,000
New +$41.2K 0.01% 189

Other funds holding SBCWW

ATW SPAC Management's SBCWW Position: Q3 2025 in Review

ATW SPAC Management held its SBC Medical Group Warrants (SBCWW) position steady in Q3 2025 at 180,629 shares worth $39.2K. The position accounts for 0.05% of the portfolio, ranked #87.

ATW SPAC Management first reported a position in SBCWW in Q3 2022 and has held it in 10 quarters since. The position peaked at $68.8K in Q3 2024. 17 funds tracked by Wall St. Rank hold SBCWW as of Q3 2025.

  • ATW SPAC Management held 180,629 shares of SBC Medical Group Warrants worth $39.2K as of Q3 2025.
  • ATW SPAC Management left its SBC Medical Group Warrants share count unchanged in Q3 2025.
  • SBC Medical Group Warrants made up 0.05% of ATW SPAC Management's portfolio in Q3 2025, its #87 holding.
  • ATW SPAC Management first reported a position in SBC Medical Group Warrants in Q3 2022 and has held it in 10 quarters since.
  • ATW SPAC Management's SBC Medical Group Warrants position peaked at $68.8K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q3 2025.

Based on ATW SPAC Management's 13F filing for Q3 2025, filed 12 Nov 2025.